Literature DB >> 20109124

Update on macrophage clearance of inhaled micro- and nanoparticles.

Marianne Geiser1.   

Abstract

BACKGROUND: Lung macrophages, that is, the intravascular, interstitial, pleural, and surface macrophages, are part of the mononuclear phagocyte system. They are derived from the hematopoietic stem cell in the bone marrow with the monocytes as their putative precursors. Macrophages residing on the inner surfaces of the lungs and immersed within the lung lining layer, that is, the alveolar and the airway macrophages, are constantly exposed to the environment; it is those cells that are recognized as first line of cellular host defense. METHODS AND
RESULTS: Phagocytic uptake of inhaled and deposited particles is the main mechanism to remove insoluble micrometer-sized particles from the lung surfaces, where mucociliary transport, cough, or sneezing fail or are absent. Phagocytosis requires an intact cytoskeleton and is most efficient when mediated by Fc-receptors, but complement and scavenger receptors like MARCO and CD206 are just as important. The main pathway for the clearance of macrophage-associated particles is by mucociliary transport; to a lesser degree and species specific, particle-containing macrophages may reenter into the interstitium and go from there to the lymphatics. Inhaled nanometer-sized particles that deposit along the entire respiratory tract, however, are not efficiently phagocytosed by surface macrophages.
CONCLUSIONS: Uptake by spontaneous or stimulated (macro-) pinocytosis or electrokinetic's phenomena may become more important. In addition, translocation of nanometer-sized particles into the interstitium and to the blood circulation brings them into contact with other fluids; altered particle properties may influence particle uptake. Moreover, translocated particles may interact with lung macrophage populations that were previously not considered of great significance for the clearance of inhaled particles.

Entities:  

Mesh:

Year:  2010        PMID: 20109124     DOI: 10.1089/jamp.2009.0797

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  76 in total

1.  Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.

Authors:  Suzanne M D'Addio; John Gar Yan Chan; Philip Chi Lip Kwok; Bryan R Benson; Robert K Prud'homme; Hak-Kim Chan
Journal:  Pharm Res       Date:  2013-07-27       Impact factor: 4.200

2.  Following the concentration of polymeric nanoparticles during nebulization.

Authors:  Moritz Beck-Broichsitter; Marie-Christine Knuedeler; Thomas Schmehl; Werner Seeger
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

3.  Internalization of SiO₂ nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf.

Authors:  Sandra Vranic; Ignacio Garcia-Verdugo; Cécile Darnis; Jean-Michel Sallenave; Nicole Boggetto; Francelyne Marano; Sonja Boland; Armelle Baeza-Squiban
Journal:  Environ Sci Pollut Res Int       Date:  2013-01-05       Impact factor: 4.223

Review 4.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

5.  In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.

Authors:  Yi-Bo Wang; Alan B Watts; Jay I Peters; Sha Liu; Ayesha Batra; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2014-05-14       Impact factor: 3.246

Review 6.  Perturbation of pulmonary immune functions by carbon nanotubes and susceptibility to microbial infection.

Authors:  Brent E Walling; Gee W Lau
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

7.  Titanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice.

Authors:  Namasivayam Ambalavanan; Andrei Stanishevsky; Arlene Bulger; Brian Halloran; Chad Steele; Yogesh Vohra; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-07       Impact factor: 5.464

Review 8.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

9.  Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature.

Authors:  Kamrun Nahar; Shahriar Absar; Brijeshkumar Patel; Fakhrul Ahsan
Journal:  Int J Pharm       Date:  2014-01-21       Impact factor: 5.875

10.  Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein D.

Authors:  Carsten Schleh; Veit J Erpenbeck; Carla Winkler; Hans D Lauenstein; Matthias Nassimi; Armin Braun; Norbert Krug; Jens M Hohlfeld
Journal:  Respir Res       Date:  2010-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.